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Summary
Excessive ultraviolet radiation (UVR) exposure induces erythema, mediated in part by prostaglandin-E2
(PGE2). While keratinocytes are a major PGE2 source, epidermal melanocytes (EM) also express PGE2-produc-
tion machinery. It is unclear whether EM-produced PGE2 contributes to UVR-induced skin inﬂammation, and
whether this is correlated with melanogenesis. Epidermal melanocytes were cultured from skin phototype-1
and -4 donors, followed by assessment of PGE2 production and melanogenesis. Epidermal melanocytes
expressed cytoplasmic phospholipase-A2, cyclooxygenase-1, cytoplasmic prostaglandin-E synthase and micro-
somal prostaglandin-E synthase-1, -2. Epidermal melanocytes produced PGE2 under basal conditions, which
increased further after arachidonic acid stimulation. Epidermal melanocytes expressed cyclooxygenase-2
(COX-2) mRNA and a selective COX-2 inhibitor (NS-398) reduced PGE2 production. Ultraviolet B-induced PGE2
production was positively correlated with skin phototype-1, despite variability between individual EM donors.
By contrast, there was no correlation between PGE2 production by EM and their melanogenic status. Thus,
EM may contribute to UVR-induced erythema, with role of donor skin phototype more important than their
melanogenic status.
Introduction
Exposure of intact skin to ultraviolet radiation (UVR)
results in a number of responses including melanogene-
sis, generation of oxidative stress, vasodilation (skin
erythema) and leukocyte inﬁltration (Tran et al., 2008).
Vasodilation is known to be mediated in part by the pro-
inﬂammatory eicosanoid prostaglandin-E2 (PGE2), with
nitric oxide (NO) also contributing (Rhodes et al., 2001,
2009). Prostaglandin-E2 is present in blister ﬂuid
obtained from ultraviolet B (UVB)-irradiated skin exhib-
iting erythema, while treatment with indomethacin [a
Signiﬁcance
Low skin phototype individuals fail to tan effectively and are also more likely than higher skin phototypes
to experience a PGE2-associated erythema after excessive UVR-exposure. The nature of this inverse rela-
tionship between melanogenesis and UVR-induced erythema remains unclear. Here, we show that UVR
can stimulate PGE2 synthesis in normal human epidermal melanocytes in primary culture and remarkably
does so in a skin phototype-dependent but melanogenesis-independent manner. Thus, skin phototype
may be a better predictor than absolute melanin content of how melanocytes may contribute to the UVR-
associated inﬂammatory cascade in human skin.
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irradiation reduces the erythema (Rhodes et al., 2001,
2009). Similarly, inhibition of NO synthases with
L-NAME also reduces UVB-erythema (Rhodes et al.,
2001). A major source of PGE2 and NO is thought to be
the keratinocyte, as these cells produce these inﬂam-
matory mediators in response to UVB (Kang-Rotondo
et al., 1993; Rome ´ro-Graillet et al., 1997). However,
more recently it has been suggested that epidermal
melanocytes (EM) may also be a source of these inﬂam-
matory mediators, as these cells express some of the
cellular machinery required for PGE2 production, i.e.
COX-1 and COX-2 mRNA (Nicolaou et al., 2004). More-
over, EM have also been shown to produce NO in
greater amounts than keratinocytes (Tsatmali et al.,
2000).
Ultraviolet radiation (both UVA and UVB) is known to
increase levels of oxidative stress within cells (Malorni
et al., 1996), which can activate cytoplasmic phospholi-
pase A2 (cPLA2) (Chen et al., 1996). Cytoplasmic phos-
pholipase A2 hydrolyses arachidonic acid (AA) from
membrane phospholipids, thus rendering it as a sub-
strate for eicosanoid formation (Burke and Dennis,
2009). Free AA can be converted enzymatically to pros-
taglandin H2 (PGH2) by the action of the COX enzymes
and then to PGE2 by the action of the terminal prosta-
glandin E synthase (PGES) enzymes (Murakami et al.,
2002). Three isoforms of PGES have been described;
two with preferential coupling to the two COX
pathways (cPGES couples preferentially to COX-1 and
mPGES-1 to COX-2, while mPGES-2 shows little prefer-
ence for either pathway) (Murakami et al., 2003).
Ultraviolet radiation-induced erythema is reported to
be greater in the skin of individuals who contain less
melanin [i.e. skin phototype-1 and 2 (SPT-1 and 2)], than
in more pigmented skin phototypes (SPT 3–6) (Li and
Chu, 2007). Therefore, we have hypothesized that EM
that do not or cannot produce signiﬁcant melanin may
be more likely instead to produce PGE2. In this way,
these EM may contribute more to inﬂammation than to
melanin production. However, it is not completely
understood whether EM in the skin of individuals with
SPT-1 and 2 are intrinsically incapable of producing mel-
anin or simply not receiving relevant paracrine cues
from their keratinocyte partner in the epidermal–melanin
unit (Fitzpatrick and Breathnach, 1963). Therefore, it
would be of signiﬁcant interest to determine whether
there is a correlation between PGE2 production by EM
in response to UVR and their capacity for melanogene-
sis, as this could suggest that melanocytes in low or
‘non-tanning’ individuals may be more susceptible to
contributing to UVR-induced inﬂammation. The expres-
sion and activity of melanogenic enzymes [including
tyrosinase, tyrosinase-related protein-1 (TRP-1) and
dopachrome tautomerase (DCT)] are important in deter-
mining the amount and type of melanin produced by
EM. For example, whether eumelanin is composed of
5,6-dihydroxyindole (brown) or 5,6-dihydroxyindole car-
boxylic acid (black) subunits depends on the expression
and activity of DCT (Maeda et al., 1997).
The aim of this study was threefold. First, we investi-
gated whether EM can actually produce PGE2 under
baseline (or AA-stimulated) conditions and whether this
production is altered after UVR-exposure. Second, we
assessed which components of the PGE2 synthetic
pathway are expressed by normal human adult primary
EM, and so attempted to determine the likely route for
PGE2 production in these cells. Third, we investigated
whether there is a correlation between PGE2 production
by EM in response to UVB and their capacity for mela-
nogenesis, so that we may provide evidence as to how
PGE2 production may be regulated in these cells.
Results of this study showed that EM can indeed
produce PGE2 under a number of experimental condi-
tions, including in response to UVB. There may be mul-
tiple potential enzymatic routes to PGE2 formation by
EM which may highlight the importance of this pro-
inﬂammatory eicosanoid to EM. The level of production
of this pro-inﬂammatory mediator was variable between
primary cultures of different EM donors, but appeared
to correlate overall with donor skin phototype. By con-
trast, PGE2 production did not correlate with baseline
melanin levels, tyrosinase expression⁄activity or TRP-1
or DCT expression. Therefore, we suggest that an
individual’s skin phototype may be a more useful
indicator of their EM ability to produce PGE2 and that
melanogenesis and PGE2 production appear to be
unrelated in EM.
Results
EM produce PGE2 under both basal and AA-
stimulated conditions
The levels of PGE2 production by EM were low under
basal conditions (Figure 1A). Seven of 10 donor-derived
primary EM cultures produced detectable amounts of
PGE2 under basal conditions (Figure 1A). Levels of basal
PGE2 production in these cells ranged from 20
(±1) pg⁄million cells to 176 (±15) pg⁄million cells. In
order to investigate the intrinsic potential of EM for
PGE2 production exogenous AA was added to the cul-
ture medium. After stimulation with exogenous AA
(3 lM for 24 h), PGE2 production was markedly
increased and was now detectable in all 10 donor-
derived primary EM cultures investigated (Figure 1A),
conﬁrming the presence of active COX and PGES
isoforms in these cells. Furthermore, the level of PGE2
production by these AA-stimulated primary EM cultures
was again highly variable, ranging from 86 (±8)
pg⁄million cells to 1339 (±73) pg⁄million cells. Keratino-
cytes (used as a positive control for PGE2 production)
produced PGE2 at a level of 155 (±9) pg⁄million cells
under basal conditions, and signiﬁcantly more, 2829
(±373) pg⁄million cells, after AA stimulation.
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in SPT-1-derived EM than SPT-4-derived EM
In order to investigate the effect of skin phototype of
the EM donor on the potential for PGE2 production
in response to AA, data from all SPT-1 and SPT-4 EM
cultures were pooled by skin phototype (Figure 1B).
Data showed that EM from SPT-1 donors produced on
average more PGE2 than EM derived from individuals
with SPT-4 in response to AA (i.e. SPT-1 EM produced
PGE2 at a level of 610 (±126) pg⁄million cells post-AA
stimulation, while EM from SPT-4 donors produced
PGE2 at 285 (±40) pg⁄million cells post-AA stimulation.
EM express the cellular machinery required
to produce PGE2
The expression of enzymes required for the production
of PGE2 (Murakami et al., 2002) was investigated in
EM. Primary EM cultures from all 10 donors expressed
cPLA2, COX-1, cPGES, mPGES-1 and mPGES-2 proteins
(Figure 2A). By contrast, COX-2 protein could not clearly
be detected in EM cultures from any of the 10 donors
either under basal conditions, in response to UVB irradi-
ation (73 mJ⁄cm
2) or after exposure to H2O2 (50 lM for
48 h) (Figure 2C). However, COX-2 mRNA was detected
in these cells (Figure 2B).
Indomethacin and NS-398 reduce PGE2 production
in EM
In order to further investigate the involvement of the
two COX isoforms in PGE2 production in EM, indometh-
acin (a non-selective COX inhibitor) and NS-398 (a
selective COX-2 inhibitor) were employed. In four out of
ﬁve EM cultures investigated, both indomethacin and
NS-398 reduced PGE2 production. For example, under
basal conditions indomethacin reduced PGE2 production
in M20 EM from 176 (±15) pg⁄million cells to 61
(±13) pg⁄million cells and NS-398 reduced PGE2 produc-
tion to 31 (±8) pg⁄million cells (Figure 3A). However, in
the primary EM culture obtained from individual 37,
only indomethacin reduced PGE2 production i.e. from
20 (±1) pg⁄million cells under basal conditions to 9
(±1) pg⁄million cells post-indomethacin stimulation
(Figure 3A). Both indomethacin and NS-398 reduced
PGE2 production in the keratinocyte primary culture. For
example, under basal conditions indomethacin reduced
PGE2 production from 155 (±9) pg⁄million cells to 100
(±7) pg⁄million cells and NS-398 reduced PGE2 produc-
tion to 114 (±3) pg⁄million cells (Figure 3B).
PGE2 production in EM is increased by UVB
Ultraviolet B causes inﬂammation in the skin, in part
mediated by PGE2 (Rhodes et al., 2001, 2009). In order
to investigate the potential involvement of EM in the
sunburn response, PGE2 production was examined in
these cells in response to UVB. Prostaglandin E2 pro-
duction was statistically and signiﬁcantly increased in
primary EM cultures from 4 of 10 donors (M20, 24, 29
and 45) with a positive trend in a further two cultures
(23 and 40) 24 h after 73 mJ⁄cm
2 UVB (Figure 4A). For
example, in EM derived from individual M20, PGE2
A
B
Figure 1. Epidermal melanocytes (EM)
and keratinocytes (K) produce
prostaglandin-E2 (PGE2) under basal and
arachidonic acid (AA) stimulated
conditions. (A) AA (3 lM) incubation for
24 h increased PGE2 production from
basal levels in all 10 primary EM cultures
and 1 primary K culture. (B) EM data
shown in ﬁgure (A) pooled by skin
phototype. B (basal conditions), AA (3 lM
AA for 24 h), SPT (skin phototype). Cell
cultures: M20, 23, 24, 29, 37, 40, 42, 45,
48, 50 and K. Error bars expressed as
mean ± SEM: (A) n = 3, (B) n = 15.
P < 0.01 = **, P < 0.001 = ***.
Gledhill et al.
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cells under basal conditions to 479 (±44) pg⁄million
cells post-UVB. The level of PGE2 synthesis remained
unchanged in cells from four other individuals (37, 42,
48 and 50) (Figure 4A). Prostaglandin E2 production in
keratinocytes was also increased in response to UVB,
i.e. from 155 (±9) pg⁄million cells under basal
conditions to 326 (±30) pg⁄million cells post-UVB
(Figure 4C).
Production of PGE2 in response to UVB is greater in
SPT-1 EM than SPT-4 EM
In order to investigate the effect of skin phototype of
EM donor on PGE2 production in response to UVB, data
for all SPT-1 and SPT-4 EM cultures were pooled
separately (Figure 4B). Only EM from SPT-1 donors
responded to UVB with a statistically signiﬁcant
increase in PGE2 production [i.e. from an average of 81
(±18) pg⁄million cells under basal conditions to an aver-
age of 191 (±51) pg⁄million cells post-UVB].
UVB-induced PGE2 production does not correlate
with melanin content, tyrosinase
expression⁄⁄activity or TRP-1 or DCT expression
in EM
In order to investigate the hypothesis that EM in non-
tanning skin may contribute to inﬂammation rather than
melanogenesis, the levels of melanin production and
melanogenic enzyme expression⁄activity were mea-
sured in primary EM cultures derived from eight donors.
No correlation was observed with baseline melanin con-
tent, baseline expression⁄activity of tyrosinase or base-
line expression of TRP-1 or DCT (Figure 5).
The pro-oxidant H2O2 stimulated PGE2 production
in EM
Ultraviolet B exposure can lead to the generation of oxi-
dative stress in cells. To investigate whether this may
contribute to PGE2 production, EM was stimulated with
the pro-oxidant H2O2. Three of the ﬁve EM cultures
investigated (M20, 23 and 37) increased their production
A
BC
Figure 2. Epidermal melanocytes (EM) under basal conditions express the cellular machinery required to produce prostaglandin-E2 (PGE2). (A)
Immunocytochemical detection of PGE2 enzyme machinery in EM. (A1) gp-100 protein (positive control for EM), (A2) cPLA2 protein, (A3)
cyclooxygenase-1 (COX-1) protein, (A4) very weak or undetectable COX-2 protein in EM, inset positive control for COX-2 in keratinocytes, (A5)
cPGES protein, (A6) mPGES-1 protein, (A7) mPGES-2 protein, (A8) negative control (no primary antibody). (B) PCR of COX-2 enzyme in EM.
(B1) molecular weight marker, (B2) negative control (no cDNA), (B3) actin mRNA, (B4) COX-2 mRNA. (C) Western Blotting analysis of COX-2
enzyme in EM. (C1) molecular weight marker, (C2) negative control (no primary antibodies), (C3) actin and COX-2 protein in FM3 melanoma
cells (COX-2 positive control), (C4) actin protein but lack of COX-2 protein expression under basal conditions, (C5) actin protein but lack of
COX-2 protein expression 24 h post 73 mJ⁄cm
2 ultraviolet B (UVB), (C6) actin protein but lack of COX-2 protein expression 48 h post 50 lM
H2O2. EM used in ﬁgure (A) was derived from individual 37 skin phototype-1 (SPT-1) but is representative of results obtained from 10
different primary EM cultures. EM used in ﬁgures (B) and (C) were derived from individual 37 but is representative of results obtained from
three different primary EM cultures (i.e. 23, 37 and 48). All lanes are from the same blot (i.e. experiment) and so are directly comparable.
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(Figure 6). For example, in EM derived from individual
M20, H2O2 increased PGE2 production from 176
(±15) pg⁄million cells under basal conditions to 390
(±13) pg⁄million cells post-H2O2 exposure. Prostaglandin
E2 production in keratinocytes was also increased in
response to H2O2, i.e. from 155 (±9) pg⁄million cells
under basal conditions to 306 (±15) pg⁄million cells
post-H2O2 exposure (Figure 6).
Discussion
Erythema occurs in the skin in response to excessive
UVB exposure and this is in part mediated by PGE2
(Rhodes et al., 2001, 2009). Although a major source of
this pro-inﬂammatory mediator is the keratinocyte
(Kang-Rotondo et al., 1993), recent evidence suggests
that EM may be potential additional contributors (Nico-
laou et al., 2004). This study supports this view
by showing that EM can produce PGE2 under different
conditions, including in response to UVB exposure. The
current study provides evidence to suggest that
although keratinocytes have a greater potential for PGE2
production (as shown by their response to 3 lMA A
stimulation), some EM can produce similar amounts in
response to a physiologically relevant stimulus, i.e.
73 mJ⁄cm
2 UVB. However, the 36:1 viable keratino-
cyte:melanocyte ratio in the epidermal–melanin unit
(Fitzpatrick and Breathnach, 1963) indicates that kera-
tinocytes are likely to be the dominant contributor of
PGE2 in UV-irradiated skin. On the basis of our current
data EM may still contribute to the PGE2 pool in UV-irra-
diated skin, and the position of EM near the dermo–
epidermal junction may result in a proportionally greater
inﬂuence (relative to the amount of PGE2 produced) on
the dermal vasculature in vivo.
Melanoma cells have previously been shown to pro-
duce PGE2 under basal conditions (Nicolaou et al.,
2004), while iridial melanocytes have been shown to
produce PGE2 in response to latanoprost acid (Bergh
et al., 2002). However, the enzymatic pathway used for
PGE2 production in these latter reports was not eluci-
dated. Data from the current study suggest that EM
have a number of ways in which they can produce
PGE2. These cells can convert free AA to prostaglandin
G2 (PGG2) and then to PGH2 via either of the two COX
isoforms, and then convert PGH2 to PGE2 by utilizing
any of the three PGES. The ability by which EM produce
PGE2 via a number of enzymatic pathways highlights
the importance of this eicosanoid to the EM. Moreover,
it has long been known that PGE2 can stimulate mela-
nogenesis (Imokawa and Motegi, 1993) as a paracrine
factor (e.g. from keratinocytes), and that EM express
some PGE2 receptor isoforms (Scott et al., 2004). The
production of this eicosanoid by EM themselves addi-
tionally suggests an autocrine role for PGE2.
Cyclooxygenase-2 protein was very weak to detect by
immunoﬂuorescence in EM in the current study, which
concurs with ﬁndings of Goulet et al. (2003) who were
also unable to detect COX-2 protein in EM. This ﬁnding
may reﬂect the apparent inducible nature of COX-2,
compared with the more general ‘house-keeping’ role of
A
B
Figure 3. Indomethacin and NS-398
reduce prostaglandin E2 (PGE2) production
in epidermal melanocytes (EM) and
keratinocytes (K). (A) Incubation of EM
with indomethacin or NS-398 reduced
PGE2 production from basal or arachidonic
acid (AA) stimulated levels in ﬁve primary
EM cultures and (B) a primary
keratinocyte culture. B (basal conditions),
B + I (100 lM indomethacin for 1 h prior
to 24 h stimulation period), B + NS
(50 lM NS-398 for 1 h prior to 24 h
stimulation period), AA (3 lM AA for
24 h), AA + I (100 lM indomethacin for
1 h prior to stimulation with AA and for
24 h during stimulation), AA + NS (50 lM
NS-398 for 1 h prior to stimulation with
AA and for 24 h during stimulation). Cell
cultures: M20, 23, 37, 42, 48 and K. Error
bars expressed as mean ± SEM: (A)
n = 3, (B) n = 15. P < 0.05 = *,
P < 0.01 = **.
Gledhill et al.
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of NS-398 (a selective COX-2 inhibitor) to reduce PGE2
production in some EM cultures clearly suggests a role
for this enzyme in this system. Moreover, the ability of
NS-398 to reduce PGE2 production to levels equal to
those obtained when using a non-selective COX inhibi-
tor (indomethacin) may even indicate that COX-2 is the
major route by which PGE2 is produced in these cells.
This report may provide evidence to further support this
claim as similar results were obtained with keratino-
cytes, which are known to express COX-2 (Flockhart
et al., 2008) as also shown in the current study. How-
ever, it would seem that for some EM donors COX-2
may have little involvement in PGE2 production. In these
cells COX-1 may be the likely enzyme by which free AA
is converted to PGH2. For example, in donor 37 EM,
indomethacin but not the COX-2 speciﬁc inhibitor NS-
398, reduced PGE2 production. The clear expression of
COX-2 mRNA but not its associated protein (undetect-
able in the current study) in normal adult human EM
could be explained by: (i) although the gene is actively
transcribed much of the mRNA may not persist long
enough to undergo translation, (ii) that translation is
inhibited in some way or (iii) that the COX-2 protein
product is rapidly turned over. In support of the latter,
Mbonye et al. (2006) found that the half-life of COX-2 is
about 2 h whereas the half-life of COX-1 is greater than
12 h in mouse ﬁbroblasts. This may explain why COX-2
protein was not found in EM 24 h post-UVB exposure in
the current study. It has also been shown that transla-
tion of COX-2 mRNA requires the activity of the eIF-5A
transcription factor (Parker and Gerner, 2002), the inhibi-
tion of which impairs murine melanoma growth (Jasiuli-
onis et al., 2007) and that basal COX-2 expression in
melanoma cells is associated with malignant transfor-
mation (Kuz ´bicki et al., 2006). It remains unclear how-
ever, why COX-2 protein was still not detectable in EM
after the 48 h exposure to the pro-oxidant H2O2. In sup-
port of this ﬁnding, Giandomenicoa et al. (1997) showed
that H2O2 is rapidly degraded in cell culture medium
therefore; it may be that after 48 h incubation the level
of H2O2 was no longer adequate to induce COX-2
expression in these cells.
The current study suggests that while both AA- and
UVB-induced PGE2 production by EM may be related to
skin phototype of the EM donor, it is not correlated with
EM melanin content, tyrosinase expression⁄activity or
TRP-1 or DCT expression in vitro. Interestingly, EM
derived from individuals with pale ‘non-tanning’ SPT-1
skin were still able to produce signiﬁcant amounts of
eumelanin with time in culture and at levels that were
similar to those found in EM derived from individuals
with ‘tannable’ SPT-4 skin. Therefore, it appears unlikely
that there was any differential contribution of melanin to
ﬁltering of UVR at the level of the EM. In any event, UVR
access to the plasma membrane would be similar for all
B
A
C
Figure 4. Prostaglandin E2 (PGE2)
production in epidermal melanocytes (EM)
and keratinocytes (K) is modulated by
73 mJ⁄cm
2 ultraviolet B (UVB). (A) UVB
increased PGE2 production in 6 of 10
primary EM cultures (4 at statistical
signiﬁcance) and 1 keratinocyte culture
but had no effect in 4 of 10 EM cultures.
(B) PGE2 production in response to UVB is
increased signiﬁcantly only in EM derived
from individuals with skin phototype-1
(SPT-1). (C) Incubation with both
indomethacin and NS-398 reduced PGE2
production in response to UVB in 1 of 4
EM cultures tested and 1 keratinocyte
culture tested. B (basal conditions), UVR
(73 mJ⁄cm
2 UVB), UVR + I (1 h
preincubation with 100 lM indomethacin
then irradiation with 73 mJ⁄cm
2 UVB and
then post-incubation with 100 lM
indomethacin for 24 h), UVR + NS (1 h
preincubation with 50 lM NS-398 then
irradiation with 73 mJ⁄cm
2 UVB and then
post-incubation with 50 lM NS-398 for
24 h). Cell cultures: M20, 23, 42, 48 and
K. In (A) and (C) error bars are expressed
as mean ± SEM (n = 3), in (B) error bars
are expressed as mean ± SEM (n = 15).
P < 0.05 = *, P < 0.01 = **.
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mically within the EM. Moreover, given the similar
melanin levels in both SPT-1- or SPT-4-derived EM, it is
unlikely that UVR access to internal membranes would
differ signiﬁcantly. Thus, the observed differences in the
ability of EM from different individuals to up-regulate
PGE2 production after UVR- or AA-stimulation, could
rather reﬂect the cells’ intrinsic membrane biochemistry
and⁄or their relative expression⁄activity of PGE2-produc-
ing cellular machinery. Taken together, we propose that
PGE2 production in EM in response to UVB is unrelated
to intrinsic melanogenesis capacity and that skin photo-
type is instead largely determined by the nature of the
keratinocyte partner in the epidermal–melanin unit [pro-
viding that the EM has an intact melanocortin 1 receptor
(MC1R)]. In support of this interpretation it should be
noted that we provide SPT-1-and SPT-4-derived EM with
similar culture conditions, which included several pro-
melanogenic growth factors [e.g. endothelin-1 (ET-1),
basic ﬁbroblast growth factor (bFGF), etc.]. These may
be variably secreted by keratinocytes in the epidermal–
melanin units of different SPT skin in situ.
The component of the UVR response, which stimu-
lates production of PGE2 in EM and keratinocytes, is
likely, at least in part, to involve oxidative stress, as
PGE2 production was increased upon incubation with the
pro-oxidant H2O2. Therefore, antioxidant capacity of the
cell, rather than melanogenesis status per se, may deter-
mine the PGE2 response to UVB. Moreover, the classiﬁ-
cation of skin phototype may more accurately describe
an individual’s propensity to ‘burn’ rather than to ‘tan’.
In conclusion, we conﬁrm that EM have the capacity
to produce PGE2, and show for the ﬁrst time that the
production of this pro-inﬂammatory eicosanoid in normal
human EM can be increased by UVB exposure. How-
ever, we show that this response does not appear to
occur in a melanogenesis-dependent manner. We also
show the multiple enzymatic routes by which PGE2 can
be produced in EM and therefore, highlight the
importance of this eicosanoid to melanocyte function.
Finally, we provide evidence to suggest that some EM
can produce levels of PGE2 that are equal to or greater
than keratinocytes in response to a physiologically
relevant stimulus and so give an idea as to their relative
contribution in producing the PGE2 pool in UVR-
exposed epidermis. Therefore, we highlight the poten-
tially important role EM may play in generating a
UVB-induced erythema.
Materials and methods
Cell culture
Epidermal melanocytes were isolated from blister roofs derived
from 10 healthy white Caucasian individuals (6F, 4M, 20–39 yr,
mean 24.8 yr) with skin phototype-1 (n = 5) or 4 (n = 5) (see
Table 1). Skin phototype was assessed according to a modiﬁed
Fitzpatrick classiﬁcation, i.e. historically from the individual’s
reported propensity to sunburn and suntan following ﬁrst exposure
in summer, where phototype 1 always burns and never tans, while
phototype 4 rarely burns but tans with ease (Fitzpatrick, 1975).
Epidermal melanocytes were cultured [after selective trypsinization
A
B
C
Figure 5. Basal melanin levels and
melanogenic enzyme expression⁄activity
in primary epidermal melanocyte (EM)
cultures. (A) Basal melanin levels in
primary EM cultures, (B) basal dopa-
oxidase activity of tyrosinase and
expression of tyrosinase, tyrosinase-
related protein-1 (TRP-1) and dopachrome
tautomerase (DCT) in primary EM
cultures, (C) densitometric analysis of
tyrosinase, TRP-1 and DCT expression
normalized to actin expression. SPT (skin
phototype). All lanes are from the same
blot (i.e. experiment) and so are directly
comparable. Cell cultures: 23, 24, 29, 37,
40, 42, 45 and 50. M = modiﬁed by
glycosylation; N = native.
Figure 6. Epidermal melanocytes (EM) and keratinocytes (K)
produce prostaglandin E2 (PGE2) in response to H2O2. Hydrogen
peroxide (50 lM for 24 h) increased PGE2 production in three of
ﬁve primary EM cultures tested and in one keratinocyte culture
tested. B (basal conditions), H2O2 (50 lMH 2O2 for 24 h). Cell
cultures: M20, 23, 37, 42, 48 and K. Error bars expressed as
mean ± SEM (n = 3). P < 0.05 = *, P < 0.01 = **.
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150 lg⁄ml geneticin sulphate (G418) in 48 h cycles at the p0 to p1
stage of primary culture (Halaban and Alfano, 1984)] in a mixture of
keratinocyte–serum free medium (PromoCell, Heidelberg, Germany)
supplemented with bovine pituitary extract (BPE) (4 lg⁄ml), epider-
mal growth factor (EGF) (0.125 ng⁄ml), insulin (5 lg⁄ml), hydrocor-
tisone (0.33 lg⁄ml), epinephrine (0.39 lg⁄ml), transferrin (10
lg⁄ml), penicillin (100 U⁄ml)⁄streptomycin (100 lg⁄ml) and L-Gln
(2 mM) and Eagle’s minimal essential medium supplemented with
FBS (2%), 1x concentrated non-essential amino acid mixture, peni-
cillin (100 U⁄ml)⁄streptomycin (100 lg⁄ml), L-Gln (2 mM), bFGF
(5 ng⁄ml) and ET-1 (5 ng⁄ml) as previously described (Kauser et al.,
2004). Melanocyte identity was conﬁrmed by gp-100 immunostain-
ing of cell monolayers at passage 1. Any residual and contaminat-
ing keratinocytes were removed by a further round of selective
trypsinization. Melanoma cells (FM3) (used as a positive control for
COX-2 expression) were cultured in RPMI 1640 culture medium
(Invitrogen, Paisley, UK) supplemented with FBS (10%), penicillin
(100 U⁄ml)⁄streptomycin (100 lg⁄ml) and L-Gln (2 mM). Epidermal
keratinocytes (used as a positive control for PGE2 production) were
isolated from one healthy Caucasian individual (Table 1) and cul-
tured in keratinocyte–serum free medium (supplemented as
described previously). Cells were incubated at 37 C in a 5% CO2
atmosphere and medium was replenished every third day.
Stimulation of primary EM cultures
AA with⁄without indomethacin or NS-398
Prior to stimulation the primary cells were incubated for 24 h in
‘starved’ culture media (i.e. no FBS, BPE, EGF, insulin, hydrocorti-
sone, epinephrine and transferrin). AA (3 lM) with⁄without 100 lM
indomethacin or 50 lM NS-398 (Sigma, Poole, UK) were then
added to the cells for 24 h. Cells were also incubated in parallel in
control ‘starved’ culture media only without 3 lM AA but contain-
ing 100 lM indomethacin or 50 lM NS-398. After the 24 h stimula-
tion period the culture media was collected for analysis of PGE2
concentration. In cells stimulated with 3 lMA Ao r7 3 m J ⁄cm
2
UVB (see below), 100 lM indomethacin or 50 lM NS-398 was
added 1 h prior to the stimulation so that COX enzymes were inhib-
ited before exposure to the stimulus.
Ultraviolet radiation
Primary cell cultures cultured in ‘starved’ medium (i.e. retaining
bFGF and ET-1 as essential growth factors for EM viability) were
temporarily submerged in PBS and irradiated with 73 mJ⁄cm
2
UVB, using as a UVR source, a ﬂuorescent UVB lamp (Waldmann
UV6; emission 290–400 nm, peak 313 nm; Herbert Waldmann
GmbH, Villingen-Schwenningen, Germany). Thus, the radiation con-
sisted of approximately 34% UVA and 66% UVB. This radiation
dose was calibrated on the basis of generating a mild induction of
cellular loss (10%) from irradiated monolayers, as it was important
to induce stress-associated signalling in these cells. The PBS was
removed immediately after irradiation and replaced with fresh
‘starved’ media. This culture medium was collected after 24 h for
analysis of PGE2 concentration. Control cells were treated similarly
but not irradiated.
Immunoﬂuorescence
Primary EM cultures were incubated in ‘starved’ culture medium for
24 h and ﬁxed in ice cold methanol (Sigma) for 10 min before air
drying and rehydration in PBS. The cells were blocked with 10%
donkey serum for 90 min and washed with PBS before incubation
with primary antibody [gp-100 (1:50) (Monosan, Uden, The Nether-
lands), cPLA2 (1:200) (Santa Cruz Biotechnology, CA, USA), COX-1
(1:50) (Santa Cruz Biotechnology), COX-2 (1:200) (Cayman Chemi-
cals, Ann Arbor, MI, USA), cPGES (1:400) (Cayman Chemicals),
mPGES-1 (1:400) (Cayman Chemicals), mPGES-2 (1:400) (Cayman
Chemicals)] overnight at 4 C. Thereafter, the cells were washed and
incubated with the secondary antibody [Alexa Fluor 488 donkey anti-
goat (1:250), donkey anti-rabbit (1:100) or donkey anti-mouse (1:100)
(Invitrogen, Paisley, UK)] for 1 h at RT. Slides were then washed
with PBS, cover-slipped using mounting medium containing 4¢,6-di-
amidino-2-phenylindole (Vector, Peterborough, UK) and photo-
graphed using a confocal microscope at 630· original magniﬁcation.
Polymerase chain reaction
RNA was extracted from primary EM cultures using RNeasy isola-
tion kit (Qiagen, West Sussex, UK) according to the manufacturer’s
instructions and quantiﬁed in a spectrophotometer at 260 nm.
cDNA synthesis was performed with 3 lg of total RNA using
superscript III ﬁrst-strand synthesis super mix (Qiagen) according
to the manufacturer’s instructions. Cyclooxygenase-2 was ampliﬁed
using the primer set (Sigma): 5¢-TTCAAATGAGATTGTGGGAAAA
TTGCT-3¢ (forward) (0.125 lM) and 5¢-AGATCATCTCTGCCTGAG
TATCTTT-3¢ (reverse) (0.125 lM) (Shi et al., 2006). Actin was ampli-
ﬁed using the primer set (Sigma): 5¢-TCACCCACACTGTGCCCATC-
TACGA-3¢ (forward) (0.125 lM) and 5¢-CAGCGGAACCGCTCATT
GCCAATGG-3¢ (reverse) (0.125 lM). The cycling protocol for both
genes was: 95 C for 10 min; 45 cycles at 95 C for 0 min, 60 C for
20 s, 72 C for 30 s; and a ﬁnal extension at 72 C for 1 min. The
omission of cDNA from the reaction mixture served as a negative
control. After ampliﬁcation, 15 ll of the reaction mixture was
loaded onto a 1.5% agarose gel (Sigma) containing 1 lg⁄ml of ethi-
dium bromide (Sigma) and electrophoresed. A 100–1000 bp DNA
ladder (Invitrogen, Paisley, UK) was also loaded.
Western immunoblot analysis
The presence of COX-2 protein was assessed by immunoblotting
human EM and FM3 extracts under unstimulated and stimulated
conditions. The latter included 24 h post-irradiation with 73 mJ⁄cm
2
UVB and 48 h post-incubation with 50 lMH 2O2. The basal expres-
sion of tyrosinase, TRP-1 and DCT was assessed in human EM
extracts. Cells were lysed on ice using Laemmli’s buffer containing a
protease inhibitor cocktail (Sigma) for 4 h. Protein concentration was
measured using the modiﬁed Bradford Assay (Bio-Rad, Richmond,
CA, USA), and 35 lg of protein per well were separated by SDS–8%
PAGE under reducing conditions. Separated proteins were then
electroblotted onto polyvinylidene diﬂuoride membranes (PVDF)
Table 1. Clinical data of cell donors
Sex
Skin phototype⁄
tanning response
(low = 1; high = 4) Age (yr)
Epidermal melanocyte donor code
M20 Male 1 20
23 Female 1 32
24 Male 1 39
29 Female 1 29
37 Female 1 27
40 Male 4 31
42 Female 4 26
45 Male 4 26
48 Female 4 24
50 Female 4 33
Keratinocyte donor code
K Female 2⁄36 0
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ª 2010 John Wiley & Sons A/S 401(Immobilon, Millipore, Bedford, MA, USA), and blocked for 2 h with
5% nonfat milk (Marvel Ltd, Merseyside, UK) in PBS. The mem-
branes were immuno-probed overnight at 4 C with antibodies
against COX-2 (1:75) (Cayman Chemicals), tyrosinase (1:100) (Santa
Cruz Biotechnology), TRP-1 (1:1000) (Santa Cruz Biotechnology),
DCT (1:100) (Santa Cruz Biotechnology) and actin (1:250) (Santa Cruz
Biotechnology), followed by incubation for 2 h at RT with a horse-
radish peroxidase-conjugated donkey anti-sheep⁄goat IgG antibody
(1:600) (Serotec Ltd, Kidlington, Oxford, UK) or a horseradish peroxi-
dase-conjugated donkey anti-rabbit IgG antibody (1:1000) (GE Health-
care, Chalfont St Giles, Buckinghamshire, UK). The reactions were
detected by the Enhanced Chemiluminescence plus Western blot
detection system kit (Amersham Biosciences Ltd, Little Chalfont,
Buckinghamshire, UK). Densitometric analysis of the immunoblots
was performed (TotalLab v1.10 software, Auckland, New Zealand)
and the ratio of tyrosinase:actin, TRP-1:actin and DCT:actin expres-
sion levels calculated. This allowed for direct comparisons of expres-
sion of the aforementioned enzymes across different primary EM
cultures. To reprobe the blots the PVDF membrane was incubated at
50 C for 30 min in a buffer containing 67.5 mM Tris–HCl, pH 6.8,
100 mM b-mercaptoethanol, and 2% SDS.
Tyrosinase activity by DOPA-oxidase assay
Proteins were separated by SDS-PAGE under non-reducing condi-
tions (i.e. without boiling and without the addition of b-mercapto-
ethanol). The PVDF membrane was incubated for 3 h in 10 mM 3,
4-dihydroxy-L-Phe (L-DOPA) (Sigma). Tyrosinase catalysed the con-
version of L-DOPA to DOPA-quinone and produced a dark band on
the membrane where the enzyme was localized.
Melanin assay
Epidermal melanocyte pellets were re-suspended in 600 llo f1M
sodium hydroxide solution and boiled at 100 C for 15 min. The cell
suspension was vortexed and 200 ll of each EM sample was added
(in triplicate) to a 96-well plate. Eumelanin concentration of each EM
sample was calculated using a standard curve created with syn-
thetic eumelanin (Sigma, Poole, UK) at 100, 50, 20, 10, 5 and
1 lg⁄ml with absorbance measured at 490 nm (Kauser et al., 2004).
Prostaglandin E2 ELISA
The concentration of PGE2 in cell culture media was determined in
triplicate using a commercially available enzyme-based immuno-
assay kit (Cayman Chemicals) in accordance with the manufac-
turer’s instructions. This assay kit can reliably quantify levels of
PGE2 of 15 pg⁄ml, but can detect levels as low as 7 pg⁄ml of
PGE2. The PGE2 antibody exhibits very high selectivity for PGE
(100% with PGE2, 100% with PGE2 Ethanolamide, 43% with
PGE3, 37.4% with 8-iso PGE2, 18.7% with PGE1) and only very
minor cross-reactivity with other prostaglandins (e.g. 1.25% with
sulprostone, 1.0% with 6-keto PGF1a, 0.25% with 8-iso PGF2a and
0.02% with 13, 14-dihydro-15-keto PGE2) (Cayman Chemicals). All
cell culture media used in this ELISA method was ‘starved’ as FBS
may contain PGE2. This meant that any PGE2 that was detected
was only produced by the cells being investigated.
Statistical analysis
Data were analysed using Student’s t-test (two-tailed, type-1). Sta-
tistical signiﬁcance was accepted at the P < 0.05 level (*), P < 0.01
level (**) and P < 0.001 level (***).
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